News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Enanta Pharmaceuticals, Inc. Announces The Appointment Of Timothy D. Ocain, Ph.D. As Senior Vice President, New Product Strategy And Development


2/4/2014 7:34:18 AM

biotech jobs post your resume Help employers find you! Check out all the jobs and post your resume.

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) today announced the appointment of Timothy D. Ocain, Ph.D. as Senior Vice President, New Product Strategy and Development. Dr. Ocain has over 25 years’ experience working in the pharmaceutical and biotechnology environment with experience in medicinal chemistry, pharmacology, biochemistry, program management and preclinical and early development across multiple therapeutic areas. He is co-author on over 30 publications and co-inventor on 17 patents.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES